About AstriVax
AstriVax NV is a privately held Belgian company founded in 2022 based on vaccine technology developed at the Rega Institute (KU Leuven). AstriVax has secured a seed round of € 30 million with a strong investor syndicate to continue building the vaccine technology platform and bring the first vaccines into clinical development. The company is located in Haasrode (Leuven).
Facts about AstriVax
Facts about AstriVax
- Founding: 2022
- Focus : Service
- Industry : Pharma